Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan

Journal of Medical Virology

Volumn 81, Issue 6, 2009, Pages 973-978

  Chu, Fang Yeh ^a,b   Chiang, Shu Chuan ^c,d,e   Su, Fu Hsiung ^a   Chang, Yuan Ying ^f   Cheng, Shu Hsing ^g,h  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b YUANPEI UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d CHING YUN UNIVERSITY   (Taiwan)

^e Sunrise Clinic   (Taiwan)

^f Tzu Li Clinic   (Taiwan)

^g TAOYUAN GENERAL HOSPITAL   (Taiwan)

^h TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Hepatitis; Heroin; HIV; Injections; Substance abuse; Taiwan

Indexed keywords

DIAMORPHINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; MEMBRANE ANTIGEN; METHAMPHETAMINE; HEPATITIS ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DELTA AGENT HEPATITIS; DETOXIFICATION; EPIDEMIC; HEALTH CENTER; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INJECTION; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; SUBSTANCE ABUSE; SUPERINFECTION; TAIWAN; BLOOD; COMORBIDITY; EPIDEMIOLOGY; HEPATITIS; MIDDLE AGED; PRISONER;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

ADOLESCENT; ADULT; COMORBIDITY; HEPATITIS; HEPATITIS ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS D; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PRISONERS; SEROEPIDEMIOLOGIC STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; TAIWAN; YOUNG ADULT;

EID: 66449124039     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21481     Document Type: Article

References (37)

1. Aceijas C, Stimson GV, Hickman M, Rhodes T, United Nations Reference Group on HIV/AIDS Prevention and Care among IDU in Developing and Transitional Countries. 2004. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 18:2295-2303.
2. Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, Viduad M, Bricaire F, Opolon P, Katlama C, Poynard T. 1999. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus co-infected patients. The Multivirc Group. Hepatology 30:1054-1058. (Pubitemid 29458296)
3. Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, Snydman DR. 2001. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 32:492-497. (Pubitemid 32173638)
4. Bonacini M, Louie S, Bzowej N, Wohl AR. 2004. Survival in patients with HIV infection and viral hepatitis B or C: A cohort study. AIDS 18:2039-2045. (Pubitemid 39463357)
5. Borkowf CB. 2006. Constructing binominal confidence intervals with near nominal coverage by adding a single imaginary failure or success. Statist Med 25:3679-3695. (Pubitemid 44613902)
6. Centers for Disease Control, Department of Health, Executive Yuan, Taiwan. 2003. Statistics of communicable diseases and surveillance reports in Taiwan area. Taipei: Centers for Disease Control, Department of. Health, Executive Yuan, Taiwan.
7. Centers for Disease Control, Department of Health, Executive Yuan, Taiwan. 2005. Statistics of communicable diseases and surveillance reports in Taiwan area. Taipei: Centers for Disease Control, Department of. Health, Executive Yuan, Taiwan.
8. Centers for Disease Control Department of Health, Executive Yuan, Taiwan. 2007. Statistics of communicable diseases and surveillance reports in Taiwan area. Taipei: Centers for Disease Control, Department of Health, Executive Yuan, Taiwan.
9. Chen YM, Kou SH. 2007. HIV-1 in Taiwan. Lancet 369:623-625. (Pubitemid 46298893)
10. Chen DS, Sung JL. 1978. Hepatitis B virus infection and chronic liver disease in Taiwan. Acta Hepatogastroenterol 25:423-430. (Pubitemid 9076288)
11. Cheng SH, Chiang SC, Hsieh YL, Chang YY, Liu YR, Chu FY. 2007. Gender difference in the clinical and behavioral characteristics of Human Immunodeficiency Virus-infected injection drug users in Taiwan. J Formos Med Assoc 106:453-467.
12. Chung DC, Ko YC, Chen CJ, Wu CC, Chen ER, Liaw YF, Hwang SJ. 1988. Seroepidemiological studies on hepatitis B and D viruses infection among five ethnic groups in southern Taiwan. J Med Virol 26:411-418. (Pubitemid 19036926)
13. Colin JF, Cazals-Hatem D, Loriot MA, Martinot-Peignoux M, Pham BN, Auperin A, Degott C, Benhamou JP, Erlinger S, Valla D, Marcellin P. 1999. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 29:1306-1310. (Pubitemid 29168769)
14. Elifson KW, Klein H, Sterk CE. 2006. Predictors of sexual risk-taking among new drug users. J Sex Res 43:318-327. (Pubitemid 46032671)
15. Gaeta GB, Precone DF, Cozzi-Lepri A, Cicconi P, D'Arminio Monforte A. 2006. Multiple viral infections. J Hepatol 44:S108-S113. (Pubitemid 43053885)
16. Hsu HM, Wang YF, Lo SH, Sun HC, Yip KK, Chen JS, Chuang CH, Chen DS. 1990. Hepatitis D virus infection among intravenous drug abusers in Taiwan: Analysis of risk factors and liver function tests. J Med Virol 31:76-81. (Pubitemid 20213233)
17. Hung CC, Chen MY, Hsieh SM, Hsiao CF, Sheng WH, Chang SC. 2005. Impact of chronic hepatitis C infection on outcomes of patients with an advanced stage of HIV-1 infection in an area of low prevalence of co-infection. Int J STD AIDS 16:42-48. (Pubitemid 40193661)
18. Huo TI, Wu JC, Lin RY, Sheng WY, Chang FY, Lee SD. 1997. Decreasing hepatitis D virus infection in Taiwan: An analysis of contributory factors. J Gastroenterol Hepatol 12:747-751. (Pubitemid 27512807)
19. Jarlais Des DC, Semaan S. 2008. HIV prevention in injection drug users: 25 years and counting. Psychosom Med 70:606-611.
20. Kao JH, Chen PJ, Lai MY, Chen DS. 2002.Hepatitis D virus genotypes in intravenous drug users in Taiwan: Decreasing prevalence and lack of correlation with hepatitis B virus genotypes. J Clin Microbiol 40:3047-3049. (Pubitemid 35284986)
21. Kellerman SE, Hanson DL, McNaghten AD, Fleming PL. 2003. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis 188:571-577. (Pubitemid 37011810)
22. Ko YC, Ho MS, Chiang TA, Chang SJ, Chang PY. 1992. Tattooing as a risk of hepatitis C virus infection. J Med Virol 38:288-291. (Pubitemid 23000557)
23. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin PR. 2001. Sexual transmission of HIV-1 among injecting drug users in San Francisco, USA: Risk factor analysis. Lancet 357:1397-1401. (Pubitemid 32455367)
24. Lai SW, Ng KC, Li CI. 2004. Descriptive analysis of HBsAg and HCV antibody prevalence in patients receiving health check-ups: A hospital-based study. Mid Taiwan J Med 9:S64-S69 [In Chinese].
25. Lai SW, Chang WL, Peng CY, Liao KF. 2007. Viral hepatitis among male amphetamine-inhaling abusers. Intern Med J 37:472-477. (Pubitemid 46855078)
26. Lu SN, Chen CH, Chen TM, Lee PL, Wang JH, Tung HD, Hung CH, Lee CM, Changchien CH. 2006. Hepatitis B virus infection in adolescents in a rural township - 15 years subsequent to mass hepatitis B vaccination in Taiwan. Vaccine 24:759-765. (Pubitemid 43190082)
27. Ministry of Justice, Executive Yuan, Taiwan. 2005. Justice Statistics. Available from http://www.moj.gov.tw, Accessed March 27, 2006.
28. Nelson KE, Galai N, Safaeian M, Strathdee SA, Celentano DD, Vlahov D. 2002. Temporal trends in the incidence of Human Immunodeficiency Virus Infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. Am J Epidemiol 156:641-653.
29. Rochstroh J, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, Kirk O, Phillips A, Lederberger B, Lundgren JD. The EuroSIDA study group. 2005. Influence of hepatitis C on HIV disease progression and response to highly active antiretroviral therapy. J Infect Dis 192:992-1002.
30. Rosengard C, Anderson B, Stein MD. 2004. Intravenous drug users' HIV-risk behaviors with primary/other partners. Am J Drug Alcohol Abuse 30:225-236. (Pubitemid 38781282)
31. Stevens CE, Beasley RP, Tsui J, Lee WC. 1975. Vertical transmission of hepatitis B antigen in Taiwan. N Eng J Med 292:771-774.
32. Su FH, Chen JD, Cheng SH, Lin CH, Liu YH, Chu FY. 2007. Seroprevalence of hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national hepatitis-B vaccination program. J Med Virol 79:128-143.
33. Sung JL, Chen DS, Lai MY, Yu JY, Wang TH, Wang CY, Yu JY, Lee CY. 1984. Epidemiological study of hepatitis B virus infection in Taiwan. Chin J Gastroenterol 1:1-9.
34. UNAIDS. 2003. AIDS epidemic update. Geneva: UNAIDS.
35. UNAIDS. 2004. Report on the global HIV/AIDS epidemic. Geneva: UNAIDS.
36. UNAIDS. 2005. Reports on the global HIV/AIDS epidemic. Geneva: UNAIDS.
37. Wu JS, Chen CH, Chiang YH, Lee YC, Lee MH, Ko YC, Hu HT. 1980. Hepatitis B virus infection in Taiwan with reference to anti-HBc versus HBsAg and anti-HBs. J Formosan Med Assoc 79:760-767.